WILLIAM WON SONG
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HENDERSON, NV NPI 1386201341
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NV Novo Nordisk AS All categories
General Payments — all program years on this page
$306.34
- Category: General Payments
- Program years: PY2021–2022
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $121.70 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $121.70 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $37.78 | 3 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $20.17 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.36 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.10 | 1 |
| Lucid Diagnostics Inc. | $14.99 | 1 |
| Lilly USA, LLC | $12.30 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 887682595 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.10 | 07/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898848065 | Novo Nordisk Inc | $12.36 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899124445 | Novo Nordisk Inc | $12.35 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899169117 | Novo Nordisk Inc | $13.07 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918752029 | Lilly USA, LLC | $12.30 | 07/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 923949057 | Biohaven Pharmaceutical Holding Company Ltd. | $20.17 | 07/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 959608731 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.36 | 09/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 962724613 | Lucid Diagnostics Inc. | $14.99 | 06/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.